Welcome to LookChem.com Sign In|Join Free

CAS

  • or

112758-89-1

Post Buying Request

112758-89-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

112758-89-1 Usage

General Description

Tert-butyl2-(piperazin-1-yl)ethylcarbamate, also known as N-tert-butyl-2-(1-piperazinyl)ethylcarbamate, is a chemical compound with the molecular formula C12H24N4O2. It is a white crystalline solid with a molecular weight of 252.35 g/mol. tert-butyl2-(piperazin-1-yl)ethylcarbamate is commonly used as a pharmaceutical intermediate in the synthesis of various drugs, including antihistamines and antimicrobial agents. It exhibits a wide range of pharmacological activities, including antiviral, antitumor, and anti-inflammatory properties. Tert-butyl2-(piperazin-1-yl)ethylcarbamate is also used as a research chemical and as a building block in organic synthesis. However, it is important to handle and use this compound with caution, as it may pose health hazards if not properly handled.

Check Digit Verification of cas no

The CAS Registry Mumber 112758-89-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,2,7,5 and 8 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 112758-89:
(8*1)+(7*1)+(6*2)+(5*7)+(4*5)+(3*8)+(2*8)+(1*9)=131
131 % 10 = 1
So 112758-89-1 is a valid CAS Registry Number.
InChI:InChI=1/C13H14N2/c1-2-5-11(6-3-1)13-12-7-4-9-15(12)10-8-14-13/h1-7,9,13-14H,8,10H2

112758-89-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-Phenyl-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine

1.2 Other means of identification

Product number -
Other names 1-Phenyl-1,2,3,4-tetrahydro-pyrrolo[1,2-a]pyrazine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:112758-89-1 SDS

112758-89-1Downstream Products

112758-89-1Relevant articles and documents

A Robust, Recyclable Resin for Decagram Scale Resolution of (±)-Mefloquine and Other Chiral N-Heterocycles

Kreituss, Imants,Chen, Kuang-Yen,Eitel, Simon H.,Adam, Jean-Michel,Wuitschik, Georg,Fettes, Alec,Bode, Jeffrey W.

supporting information, p. 1553 - 1556 (2016/02/12)

Decagram quantities of enantiopure (+)-mefloquine have been produced via kinetic resolution of racemic mefloquine using a ROMP-gel supported chiral acyl hydroxamic acid resolving agent. The requisite monomer was prepared in a few synthetic steps without chromatography and polymerization was safely performed on a >30 gram scale under ambient conditions. The reagent was readily regenerated and reused multiple times for the resolution of 150 grams of (±)-mefloquine and other chiral N-heterocylces.

Substituted Sulfonamide Compounds

-

Page/Page column 35-36, (2009/07/25)

Substituted sulfonamide compounds corresponding to the formula I wherein m, n, p, Q, R1, R2, R3, R4, X, Y and Z have the respective meanings defined herein, pharmaceutical compositions containing such compounds, a process for their preparation, and the use of such compounds for the treatment and/or inhibition of pain and other conditions mediated by bradykinin receptor 1 (B1R) and/or bradykinin receptor 2 (B2R).

Substituted Tetrahydropyrrolopyrazine Compounds and the Use Thereof in the Treatment and/or Inhibition of Pain

-

Page/Page column 13-15, (2008/12/06)

Substituted tetrahydropyrrolopyrazine compounds corresponding to the formula I: processes for their preparation, pharmaceutical compositions comprising these compounds and the use of these compounds for the treatment and/or inhibition of pain and other disorders or disease states at least partly mediated by KCNQ2/3 K+ channels.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 112758-89-1